Medical anticancer treatment of lung cancer associated with comorbidities: A review. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Sculier, J.P.; Botta, I.; Bucalau, A.M.; Compagnie, M.; Eskenazi, A.; Fischler, R.; Gorham, J.; Mans, L.; Rozen, L.; Speybrouck, S.; Wang, X.; Meert, A.P.; Berghmans, Th.
• Is Part Of: Lung cancer. Volume 87:Issue 3(2015:Mar.)
• Page Start: 241
• Page End: 248
• Publication Date: 2015-03
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2015.01.007
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Comorbidities are frequent in patients with lung cancer.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Anticancer therapy has to be adapted to the patient's comorbidities.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Comorbidities impact on anticancer treatment is poorly assessed.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Level of evidence is often limited to experts' opinion and to case reports.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">There is a strong need for improving our knowledge in that field.</p> </list-item> </list> </p> </sec> </abstract>